E- Pill Pharma Ltd. has developed a novel oral drug delivery platform that replaces drug delivery by injection. Combining effective drug administration with ease of use, E-Pill Pharma’s novel medical device platform, is especially well suited to administering peptides, large molecule drugs, and small molecule, low bioavailability drugs, such as insulin, growth hormone, LMW Heparin, PTH, interferon and EPO in pill form.

Providing patients with an alternative to injectable drugs, E-Pill Pharma patented technology improves drug absorption and E-Pill's products improve patient compliance. The Company is looking for partners to jointly bring products to market.